EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
2.7.7.23 | 2-2-[(6-nitroquinazolin-4-yl)amino]ethoxy)-ethan-1-ol | - |
Mycobacterium tuberculosis | |
2.7.7.23 | 2-[2-[(6-nitroquinazolin-4-yl)amino]ethoxy]-ethan-1-ol | - |
Mycobacterium tuberculosis | |
2.7.7.23 | 4-(5-[(6-nitroquinazolin-4-yl)amino]-1,3,4-thiadiazol-2-yl)phenol | - |
Mycobacterium tuberculosis | |
2.7.7.23 | 4-(6-nitroquinazolin-4-ylamino)benzoic acid | - |
Mycobacterium tuberculosis | |
2.7.7.23 | 4-methyl-7-[(6-nitroquinazolin-4-yl)amino]-2H-1-benzopyran-2-one | - |
Mycobacterium tuberculosis | |
2.7.7.23 | 4-[(6-nitroquinazolin-4-yl)amino]-N-(pyrimidin-2-yl)benzene-1-sulfonamide | - |
Mycobacterium tuberculosis | |
2.7.7.23 | 4-[5-[(6-nitroquinazolin-4-yl)amino]-1,3,4-thiadiazol-2-yl]phenol | - |
Mycobacterium tuberculosis | |
2.7.7.23 | 6-nitro-N-(1,3-thiazol-2-yl)quinazolin-4-amine | - |
Mycobacterium tuberculosis | |
2.7.7.23 | 6-nitro-N-(3,4,5-trimethoxyphenyl)quinazolin-4-amine | - |
Mycobacterium tuberculosis | |
2.7.7.23 | 6-nitro-N-(5-phenyl-1,3,4-thiadiazol-2-yl)quinazolin-4-amine | - |
Mycobacterium tuberculosis | |
2.7.7.23 | 6-nitro-N-(pyridin-2-ylmethyl)quinazolin-4-amine | - |
Mycobacterium tuberculosis | |
2.7.7.23 | 6-nitro-N-[5-(4-methylphenyl)-1,3,4-thiadiazol-2-yl]quinazolin-4-amine | - |
Mycobacterium tuberculosis | |
2.7.7.23 | 6-nitro-N-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]quinazolin-4-amine | - |
Mycobacterium tuberculosis | |
2.7.7.23 | additional information | inhibitory potential of 4-aminoquinazolines as Mycobacterium tuberculosis N-acetylglucosamine-1-phosphate uridyltransferase (GlmUMTB) inhibitors, overview. Molecular docking using the crystal structure of GlmUMTB (PDB ID 3ST8), with bound substrates, N-acetylglucosamine-1-phosphate (NAcGlc-1-P) and uridine diphosphate-N-cetylglucosamine (UDP-GlcNAc). Analysis of inhibition of Mycobacterium tuberculosis wild-type strain H37Rv and of multiresistant strain MDR-MTB, antimycobacterial activity, MIC values for both strains; not inhibited by isoniazid | Mycobacterium tuberculosis | |
2.7.7.23 | N-(1-benzylpiperidin-4-yl)-6-nitroquinazolin-4-amine | - |
Mycobacterium tuberculosis | |
2.7.7.23 | N-(2,4-dimethylphenyl)-6-nitroquinazolin-4-amine | - |
Mycobacterium tuberculosis | |
2.7.7.23 | N-(3-methylpiperazin-1-yl)-6-nitroquinazolin-4-amine | - |
Mycobacterium tuberculosis | |
2.7.7.23 | N-(4-[(6-nitroquinazolin-4-yl)amino]benzene-1-sulfonyl)acetamide | - |
Mycobacterium tuberculosis | |
2.7.7.23 | N-(5-methyl-1,3,4-thiadiazol-2-yl)-6-nitroquinazolin-4-amine | - |
Mycobacterium tuberculosis | |
2.7.7.23 | N-carbamimidoyl-4-[(6-nitroquinazolin-4-yl)-amino]benzene-1-sulfonamide | compound with sulfaguanidine moiety at 4th position of quinazoline forms polar hydrogen bond with Glu 166 and Gln 205 via guanidine moiety. Lys 26 forms pi-pi stacking with the phenyl ring of sulfaguanidine and hydrogen bonding with the nitro functional g | Mycobacterium tuberculosis | |
2.7.7.23 | N-cyclohexyl-6-nitroquinazolin-4-amine | - |
Mycobacterium tuberculosis | |
2.7.7.23 | N-cyclopropyl-6-nitroquinazolin-4-amine | - |
Mycobacterium tuberculosis | |
2.7.7.23 | N-[4-[(6,7-dimethoxyquinazolin-4-yl)amino]phenyl]-3-methoxybenzamide | 38% inhibition; 38% inhibition at 0.05 mM | Mycobacterium tuberculosis | |
2.7.7.23 | N-[4-[(6,7-dimethoxyquinazolin-4-yl)amino]phenyl]benzamide | 44% inhibition; 44% inhibition at 0.05 mM | Mycobacterium tuberculosis | |
2.7.7.23 | N-[4-[(6-nitroquinazolin-4-yl)amino]benzene-1-sulfonyl]acetamide | - |
Mycobacterium tuberculosis | |
2.7.7.23 | N-[4-[(7-hydroxy-6-methoxyquinazolin-4-yl)amino]phenyl]benzamide | 36% inhibition; 36% inhibition at 0.05 mM | Mycobacterium tuberculosis | |
2.7.7.23 | N-[5-(2-chlorophenyl)-1,3,4-thiadiazol-2-yl]-6-nitroquinazolin-4-amine | - |
Mycobacterium tuberculosis | |
2.7.7.23 | N1-(6-nitroquinazolin-4-yl)benzene-1,2-diamine | - |
Mycobacterium tuberculosis | |
2.7.7.23 | rifampicin | - |
Mycobacterium tuberculosis |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.7.7.23 | UTP + N-acetyl-alpha-D-glucosamine 1-phosphate | Mycobacterium tuberculosis | - |
diphosphate + UDP-N-acetyl-alpha-D-glucosamine | - |
? | |
2.7.7.23 | UTP + N-acetyl-alpha-D-glucosamine 1-phosphate | Mycobacterium tuberculosis H37Rv | - |
diphosphate + UDP-N-acetyl-alpha-D-glucosamine | - |
? | |
2.7.7.23 | UTP + N-acetyl-alpha-D-glucosamine 1-phosphate | Mycobacterium tuberculosis ATCC 25618 | - |
diphosphate + UDP-N-acetyl-alpha-D-glucosamine | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.7.7.23 | Mycobacterium tuberculosis | P9WMN3 | - |
- |
2.7.7.23 | Mycobacterium tuberculosis ATCC 25618 | P9WMN3 | - |
- |
2.7.7.23 | Mycobacterium tuberculosis H37Rv | P9WMN3 | - |
- |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.7.7.23 | UTP + N-acetyl-alpha-D-glucosamine 1-phosphate | - |
Mycobacterium tuberculosis | diphosphate + UDP-N-acetyl-alpha-D-glucosamine | - |
? | |
2.7.7.23 | UTP + N-acetyl-alpha-D-glucosamine 1-phosphate | - |
Mycobacterium tuberculosis H37Rv | diphosphate + UDP-N-acetyl-alpha-D-glucosamine | - |
? | |
2.7.7.23 | UTP + N-acetyl-alpha-D-glucosamine 1-phosphate | - |
Mycobacterium tuberculosis ATCC 25618 | diphosphate + UDP-N-acetyl-alpha-D-glucosamine | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.7.7.23 | GlmU | - |
Mycobacterium tuberculosis |
2.7.7.23 | GlmUMTB | - |
Mycobacterium tuberculosis |
2.7.7.23 | N-acetylglucosamine-1-phosphate uridyltransferase | - |
Mycobacterium tuberculosis |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
2.7.7.23 | 0.0000063 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | rifampicin | |
2.7.7.23 | 0.0029 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | N-(1-benzylpiperidin-4-yl)-6-nitroquinazolin-4-amine | |
2.7.7.23 | 0.0064 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | N-carbamimidoyl-4-[(6-nitroquinazolin-4-yl)-amino]benzene-1-sulfonamide | |
2.7.7.23 | 0.0087 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | 2-2-[(6-nitroquinazolin-4-yl)amino]ethoxy)-ethan-1-ol | |
2.7.7.23 | 0.0087 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | 2-[2-[(6-nitroquinazolin-4-yl)amino]ethoxy]-ethan-1-ol | |
2.7.7.23 | 0.0104 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | N1-(6-nitroquinazolin-4-yl)benzene-1,2-diamine | |
2.7.7.23 | 0.016 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | 6-nitro-N-(1,3-thiazol-2-yl)quinazolin-4-amine | |
2.7.7.23 | 0.021 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | 6-nitro-N-(3,4,5-trimethoxyphenyl)quinazolin-4-amine | |
2.7.7.23 | 0.021 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | 6-nitro-N-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]quinazolin-4-amine | |
2.7.7.23 | 0.023 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | 6-nitro-N-(pyridin-2-ylmethyl)quinazolin-4-amine | |
2.7.7.23 | 0.026 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | 4-[(6-nitroquinazolin-4-yl)amino]-N-(pyrimidin-2-yl)benzene-1-sulfonamide | |
2.7.7.23 | 0.028 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | N-(4-[(6-nitroquinazolin-4-yl)amino]benzene-1-sulfonyl)acetamide | |
2.7.7.23 | 0.028 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | N-[4-[(6-nitroquinazolin-4-yl)amino]benzene-1-sulfonyl]acetamide | |
2.7.7.23 | 0.042 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | 4-(6-nitroquinazolin-4-ylamino)benzoic acid | |
2.7.7.23 | 0.052 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | N-(2,4-dimethylphenyl)-6-nitroquinazolin-4-amine | |
2.7.7.23 | 0.121 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | N-cyclopropyl-6-nitroquinazolin-4-amine | |
2.7.7.23 | 0.141 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | N-cyclohexyl-6-nitroquinazolin-4-amine | |
2.7.7.23 | 0.194 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | N-(3-methylpiperazin-1-yl)-6-nitroquinazolin-4-amine | |
2.7.7.23 | 0.2 | - |
above, pH and temperature not specified in the publication | Mycobacterium tuberculosis | 4-(5-[(6-nitroquinazolin-4-yl)amino]-1,3,4-thiadiazol-2-yl)phenol | |
2.7.7.23 | 0.2 | - |
above, pH and temperature not specified in the publication | Mycobacterium tuberculosis | 4-methyl-7-[(6-nitroquinazolin-4-yl)amino]-2H-1-benzopyran-2-one | |
2.7.7.23 | 0.2 | - |
above, pH and temperature not specified in the publication | Mycobacterium tuberculosis | 6-nitro-N-(5-phenyl-1,3,4-thiadiazol-2-yl)quinazolin-4-amine | |
2.7.7.23 | 0.2 | - |
above, pH and temperature not specified in the publication | Mycobacterium tuberculosis | 6-nitro-N-[5-(4-methylphenyl)-1,3,4-thiadiazol-2-yl]quinazolin-4-amine | |
2.7.7.23 | 0.2 | - |
above, pH and temperature not specified in the publication | Mycobacterium tuberculosis | N-(5-methyl-1,3,4-thiadiazol-2-yl)-6-nitroquinazolin-4-amine | |
2.7.7.23 | 0.2 | - |
above, pH and temperature not specified in the publication | Mycobacterium tuberculosis | N-[5-(2-chlorophenyl)-1,3,4-thiadiazol-2-yl]-6-nitroquinazolin-4-amine | |
2.7.7.23 | 0.2 | - |
IC50 above 0.2 mM, pH and temperature not specified in the publication | Mycobacterium tuberculosis | 4-methyl-7-[(6-nitroquinazolin-4-yl)amino]-2H-1-benzopyran-2-one | |
2.7.7.23 | 0.2 | - |
IC50 above 0.2 mM, pH and temperature not specified in the publication | Mycobacterium tuberculosis | 4-[5-[(6-nitroquinazolin-4-yl)amino]-1,3,4-thiadiazol-2-yl]phenol | |
2.7.7.23 | 0.2 | - |
IC50 above 0.2 mM, pH and temperature not specified in the publication | Mycobacterium tuberculosis | 6-nitro-N-(5-phenyl-1,3,4-thiadiazol-2-yl)quinazolin-4-amine | |
2.7.7.23 | 0.2 | - |
IC50 above 0.2 mM, pH and temperature not specified in the publication | Mycobacterium tuberculosis | 6-nitro-N-[5-(4-methylphenyl)-1,3,4-thiadiazol-2-yl]quinazolin-4-amine | |
2.7.7.23 | 0.2 | - |
IC50 above 0.2 mM, pH and temperature not specified in the publication | Mycobacterium tuberculosis | N-(5-methyl-1,3,4-thiadiazol-2-yl)-6-nitroquinazolin-4-amine | |
2.7.7.23 | 0.2 | - |
IC50 above 0.2 mM, pH and temperature not specified in the publication | Mycobacterium tuberculosis | N-[5-(2-chlorophenyl)-1,3,4-thiadiazol-2-yl]-6-nitroquinazolin-4-amine |
EC Number | General Information | Comment | Organism |
---|---|---|---|
2.7.7.23 | physiological function | the bifunctional enzyme is found exclusively in bacteria and catalyzes the development of uridine diphosphate-N-acetylglucosamine (UDP-GlcNAc), an essential intermediate in peptidoglycan biosynthesis in Mycobacterium tuberculosis (Mtb) | Mycobacterium tuberculosis |